NASDAQ:INKT

MiNK Therapeutics, Inc.

Stock

USD

Last Close

13.66

06/11 21:00

Market Cap

30.21M

Beta: -

Volume Today

858

Avg: 87.89K

PE Ratio

0.21

PFCF: −1.71

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-23.80M -	-16.24M 31.78%	-30.21M 86.05%	-27.99M 7.35%	-22.46B 80,131.82%
depreciation and amortization	36.82K -	55.06K 49.55%	77.96K 41.59%	121.75K 56.17%	204.62M 167,964.62%
deferred income tax			-355.51K -
stock based compensation	219.57K -	87.83K 60.00%	1.74M 1,886.50%	3.03M 73.49%	3.86B 127,437.58%
change in working capital	4.12M -	-324.93K 107.90%	3.74M 1,249.82%	8.77M 134.64%	-1.92B 21,973.48%
accounts receivables	3.43M -	1.80M 47.52%
inventory	-3.43M -	-1.80M 47.52%
accounts payables	886.67K -	607.86K 31.44%	-152.04K 125.01%	2.66M 1,850.02%	-1.92B 72,167.77%
other working capital	3.23M -	-932.79K 128.89%	3.89M 516.83%	6.11M 57.04%	1.92B 31,305.43%
other non cash items	4.49M -	8.08M 80.18%	12.18M 50.71%	-2.79M 122.91%	2.63B 94,350.95%
net cash provided by operating activities	-14.94M -	-8.34M 44.21%	-12.83M 53.84%	-18.87M 47.09%	-15.76B 83,446.10%
investments in property plant and equipment	-426.47K -	-95.21K 77.67%	-248.98K 161.50%	-250.05K 0.43%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites					-73.56M -
net cash used for investing activites	-426.47K -	-95.21K 77.67%	-248.98K 161.50%	-250.05K 0.43%	-73.56M 29,318.99%
debt repayment	-11.44M -	-11.11M 2.89%	-9.46M 14.82%
common stock issued		901 -	39.80M 4,416,922.97%	293.52M 637.54%	1.01B 244.56%
common stock repurchased				-157.19K -
dividends paid
other financing activites	22.87M -	22.21M 2.89%	18.92M 14.82%	-293.52M 1,651.48%	-1.42B 383.28%
net cash used provided by financing activities	11.44M -	11.11M 2.88%	49.26M 343.50%	-155.60K 100.32%	-407.17M 261,580.99%
effect of forex changes on cash	-122.08K -	-281.18K 130.33%	16.90K 106.01%	19.39K 14.71%	-25.25M 130,355.35%
net change in cash	-4.06M -	2.39M 158.96%	36.20M 1,413.20%	-19.25M 153.19%	-16.27B 84,398.05%
cash at beginning of period	4.36M -	299.04K 93.13%	2.69M 799.94%	38.89M 1,345.06%	19.64B 50,391.94%
cash at end of period	299.04K -	2.69M 799.94%	38.89M 1,345.06%	19.64M 49.51%	3.37B 17,048.48%
operating cash flow	-14.94M -	-8.34M 44.21%	-12.83M 53.84%	-18.87M 47.09%	-15.76B 83,446.10%
capital expenditure	-426.47K -	-95.21K 77.67%	-248.98K 161.50%	-250.05K 0.43%
free cash flow	-15.37M -	-8.43M 45.14%	-13.08M 55.06%	-19.12M 46.20%	-15.76B 82,353.33%

All numbers in USD (except ratios and percentages)